EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

How should we address non-reproducibility?

Torben Göpel iD

Philosophical Transactions B · 19.03.2026 · 381 (1946)

DOI: 10.1098/rstb.2025.0057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Philosophical Transactions B, online erschienen am 19.03.2026. Verfasst von Torben Göpel. Beteiligte Einrichtung: Multiscale Biology, Johann-Friedrich-Blumenbach-Institut für Zoologie and Anthropologie, Georg-August-Universität Göttingen, Göttingen, Niedersachsen…. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Alexander von Humboldt-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inter-experimental variability poses a significant challenge to reproducibility in experimental biology, hindering scientific progress and the translation of research findings. This variability arises from numerous factors, including subtle differences in reagents, equipment calibration, environmental conditions and unaccounted biological variation. Despite the existence of guidelines such as ARRIVE (Animal Research: Reporting of In Vivo Experiments) and MDAR (Materials Design Analysis Reporting), the reporting of crucial experimental details often remains incomplete or inconsistent across studies. Recent analyses have suggested that the insufficient reporting of materials and methods may substantially contribute to non-reproducibility in biological research. This underscores the need for more comprehensive and standardized reporting practices as the best approach to ensure good science. To address this issue, publishers, editors and reviewers must enforce existing standards more rigourously, while authors and researchers should prioritize the comprehensive reporting of experimental details. Innovative approaches such as experimental heterogenization and open science initiatives are emerging to enhance reproducibility. A multifaceted approach involving stricter guideline enforcement, recognition of replication studies and fostering a culture that values reproducibility over publication speed and sensationalization is essential for improving the reliability and credibility of experimental biology research. This article is part of the theme issue ‘Embracing variability in comparative physiology: why it matters and what to do with it’.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignReproducibility of ResultsAnimals

Stichwörter der Autor:innen

open sciencepublishing policyreporting guidelinesreproducibility crisisscientific rigour

Autor:innen und Institutionen

  • Multiscale Biology, Johann-Friedrich-Blumenbach-Institut für Zoologie and Anthropologie, Georg-August-Universität Göttingen, Göttingen, Niedersachsen, Germany.
  • Department of Biological Sciences, University of North Texas, Denton, TX, USA.

ORCID-Profile: Torben Göpel

Förderung

  • Deutsche Forschungsgemeinschaft
  • Alexander von Humboldt-Stiftung

Zitieren

APA

Göpel, T. (2026). How should we address non-reproducibility?. Philosophical Transactions B, 381(1946). https://doi.org/10.1098/rstb.2025.0057

Vancouver

Göpel T. How should we address non-reproducibility?. Philosophical Transactions B. 2026;381(1946). doi:10.1098/rstb.2025.0057

BibTeX
@article{Gpel2026,
  author = {Göpel, Torben},
  title = {How should we address non-reproducibility?},
  journal = {Philosophical Transactions B},
  year = {2026},
  volume = {381},
  number = {1946},
  doi = {10.1098/rstb.2025.0057}
}
Kostenlos starten →